Pharmacokinetics and pharmacodynamics of tucaresol, an antisickling agent, in healthy volunteers.
1. Tucaresol is an orally administered antisickling agent which increases the oxygen affinity of haemoglobin. 2. The pharmacokinetics, effects on moderate graded exercise and psychometric performance of tucaresol were examined in a double-blind, placebo-controlled, parallel groups study in 12 healthy men. 3. Three doses of tucaresol were given at 48 h intervals intended to modify 15, 25 and 32.5% of a subject's haemoglobin to a high affinity form (%MOD). 4. Mean peak %MOD was 34%. Mean Cmax values in plasma and erythrocytes were 81.4 and 1459 micrograms ml-1, respectively. 5. Heart rate, compared with baseline, increased in the tucaresol group with the greatest changes at the highest %MOD and workload. There were no differences between groups in psychometric test performance. 6. Three volunteers on active drug developed fever, rash and tender cervical lymphadenopathy with onset 7-10 days from the start of dosing, suggesting an immune mechanism. 7. The acute increase in oxygen affinity with tucaresol is physiologically well-tolerated, but the utility of tucaresol in the management of sickle cell disease will depend on the identification of a dosing regimen with a lower incidence of drug allergy.
Rolan
P E
PE
Department of Clinical Pharmacology, Wellcome Research Laboratories, Beckenham, Kent, UK.
Mercer
A J
AJ
Wootton
R
R
Posner
J
J
D000284:Administration, Oral; D000328:Adult; D001547:Benzaldehydes / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology; D001565:Benzoates / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D015444:Exercise / Q000502:physiology; D006207:Half-Life; D006339:Heart Rate / Q000187:drug effects*; D006454:Hemoglobins / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D008297:Male; D010100:Oxygen / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D011597:Psychomotor Performance / Q000187:drug effects; D000637:Transaminases / Q000097:blood; D044465:White People
D001547:Benzaldehydes; D001565:Benzoates; D006454:Hemoglobins; D000637:Transaminases; C059629:tucaresol; D010100:Oxygen